TIMP1 and breast carcinoma: Interestingly, in MCF-7 breast cancer cell overexpression of TIMP-1 increases the expression and phosphorylation of proteins involved in the DNA damage response and confers resistance to epirubicin or topoisomerase inhibitors but not to cisplatin, suggesting that it could impact on the response to chemotherapy in a cell-dependent manner [24].